Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
1.010
-0.040 (-3.81%)
At close: Dec 20, 2024, 4:00 PM
0.970
-0.040 (-3.96%)
After-hours: Dec 20, 2024, 7:57 PM EST
Bone Biologics Employees
Bone Biologics had 2 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,676,547
Market Cap
2.49M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Venus Concept | 304 |
Xylo Technologies | 84 |
Fresh2 Group | 75 |
Aditxt | 47 |
NovaBay Pharmaceuticals | 26 |
Catheter Precision | 14 |
Palisade Bio | 9 |
Shuttle Pharmaceuticals Holdings | 8 |
BBLG News
- 2 months ago - Bone Biologics Appoints Phillip T. Meikle to its Board of Directors - Business Wire
- 3 months ago - Bone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Business Wire
- 5 months ago - Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds - Business Wire
- 6 months ago - First Two Patients Treated in Pilot Clinical Study with Bone Biologics' NB1 Bone Graft Device in Spine Fusion - Business Wire
- 10 months ago - Bone Biologics Announces Closing of $2.0 Million Public Offering - Business Wire
- 10 months ago - Bone Biologics Announces Pricing of $2.0 Million Public Offering - Business Wire
- 10 months ago - Bone Biologics Reports Progress With NB1 Clinical Program - Business Wire
- 1 year ago - Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors - Business Wire